Clearside Biomedical
Clearside Biomedical Logo
About Clearside Biomedical
Clearside Biomedical Inc is a biopharmaceutical company specializing in the development of therapies for blinding diseases of the eye, particularly those affecting the retina and choroid. The company is a leader in suprachoroidal drug delivery, offering XIPERE, the first FDA-approved therapy for macular edema associated with uveitis, and developing additional treatments such as CLS-AX for wet age-related macular degeneration. Clearside Biomedical leverages its proprietary technology to deliver drugs directly to the back of the eye, aiming to improve outcomes for patients with serious ocular conditions.
Address
900 North Point Parkway, Suite 200
Alpharetta, 30005
United States
Year founded
2011
Number of employees
0-100
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
